US2015305827A1PendingUtilityA1
Bioabsorbable stent with radiopaque layer and method of fabrication
Assignee: ABBOTT CARDIOVASCULAR SYSTEMSPriority: Dec 5, 2007Filed: Jul 2, 2015Published: Oct 29, 2015
Est. expiryDec 5, 2027(~1.3 yrs left)· nominal 20-yr term from priority
A61L 31/12A61F 2/915A61B 2019/5466A61B 19/54A61B 90/39A61L 31/148A61L 31/18A61B 2090/3966
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Embodiments of a stent and methods of fabricating the same with a bioabsorbable radiopaque layer are disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A bioabsorbable stent comprising a stent scaffolding including a radiopaque layer and a support layer, the radiopaque layer comprising radiopaque material mixed within a first bioabsorable polymer, the support layer formed from a second bioabsorbable polymer.
2 . The stent of claim 1 , wherein the support layer is adapted to be primarily responsible for maintaining patency within a vascular lumen.
3 . The stent of claim 1 , wherein the second bioabsorbable polymer has a higher strength and modulus than the first bioabsorbable polymer.
4 . The stent of claim 1 , wherein the radiopaque layer is a luminal or an abluminal layer.
5 . The stent of claim 1 , wherein the radiopaque layer is an abluminal layer and the support layer is a luminal layer.
6 . The stent of claim 1 , wherein the radiopaque layer is a luminal layer and the support layer is an abluminal layer.
7 . The stent of claim 1 , further comprising a second support layer formed from the second bioabsorbable polymer, the radiopaque layer disposed between the first and second support layers.
8 . The stent of claim 1 , further comprising a second radiopaque layer formed from the first bioabsorbable polymer, the support layer disposed between the first and second radiopaque layers.
9 . The stent of claim 1 , wherein the radiopaque material comprises particles.
10 . The stent of claim 9 , wherein the particles are nanoparticles.
11 . The stent of claim 1 , wherein the radiopaque material comprises a corrodible metal, a biostable metal, metallic salts, or a combination thereof.
12 . The stent of claim 1 , wherein the radiopaque material is selected from the group consisting of iodine, bromine, barium, tungsten, bismuth, magnesium, iron, zinc, ferrous sulfate, ferrous gluconate, ferrous carbonate, ferrous chloride, ferrous fumarate, ferrous iodide, ferrous lactate, ferrous succinate, barium sulfate, bismuth subcarbonate, bismuth potassium tartrate, bismuth sodium iodide, bismuth sodium tartrate, bismuth sodium triglycollamate, bismuth subsalicylate, zinc acetate, zinc carbonate, zinc citrate, zinc iodate, zinc iodide, zinc lactate, zinc phosphate, zinc salicylate, zinc stearate, zinc sulfate, and combinations thereof.
13 . The stent of claim 1 , wherein the radiopaque material comprises between 5% and 40% by volume of the radiopaque layer.
14 . The stent of claim 1 , wherein the support layer is 2 to 10 times thicker than the radiopaque layer.
15 . The stent of claim 1 , wherein the thickness of the radiopaque layer is 5-100 μm.
16 . The stent of claim 1 , further comprising a therapeutic layer disposed above or below the radiopaque layer.Join the waitlist — get patent alerts
Track US2015305827A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.